Genesee Capital Advisors’s Oracle ORCL Stock Holding History
Bought
Maintained
Sold
Other funds holding ORCL
Genesee Capital Advisors's ORCL Position: Q3 2026 in Review
Genesee Capital Advisors sold out of Oracle (ORCL) in Q3 2026, closing a stake of 1,368 shares — an estimated $201K sold.
Genesee Capital Advisors first reported a position in ORCL in Q1 2024 and held it in 10 quarters. The position peaked at $482K in Q3 2025. 2,211 funds tracked by Wall St. Rank hold ORCL as of Q3 2026.
- Genesee Capital Advisors reported no remaining Oracle position as of Q3 2026 after selling out during the quarter.
- Genesee Capital Advisors sold 1,368 Oracle shares in Q3 2026, an estimated $201K.
- Genesee Capital Advisors first reported a position in Oracle in Q1 2024 and held it in 10 quarters.
- Genesee Capital Advisors's Oracle position peaked at $482K in Q3 2025.
- 2,211 funds tracked by Wall St. Rank held Oracle as of Q3 2026.
Based on Genesee Capital Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.